US Patent Issued to LAMKAP BIO ALPHA on Oct. 14 for "Bispecific antibodies against CEACAM5 and CD3" (Swiss, German Inventors)

ALEXANDRIA, Va., Oct. 21 -- United States Patent no. 12,441,807, issued on Oct. 14, was assigned to LAMKAP BIO ALPHA AG (Pfaeffikon, Switzerland).

"Bispecific antibodies against CEACAM5 and CD3" was invented by Klaus Strein (Weinheim, Germany) and Sara Majocchi (Grand Lancy, Switzerland).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to bispecific antibodies which bind to human carcinoembryonic antigen CEACAM5 (CEA) and human CD3Epsilon. In addition, the present invention relates to polynucleotides encoding such bispecific antibodies and vectors and host cells comprising such polynucleotides. The invention further relates to methods for selecting and producing such antibodies and...